Mitchell Cohen, MD FACC FHRS

Mitchell Cohen MD FACC FHRS is the current Co-Director of the Heart Center and Chief of Pediatric Cardiology at Inova LJ Murphy Children’s Hospital and Professor of Pediatrics at the UVA School of Medicine. Dr. Cohen graduated from Temple University School of Medicine and then completed a pediatric internship, residency, cardiology fellowship, and subspecialty training in pediatric electrophysiology at the Children's Hospital of Philadelphia. Dr. Cohen remained on faculty at the Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine for 6 years before relocating to Arizona where he was Co-Director of the Heart Center at Phoenix Children’s Hospital for more than a decade.
In 2017, Dr. Cohen assumed the pediatric cardiology leadership position at Inova. Dr. Cohen’s research interests address long-term outcomes of children with cardiovascular implantable electronic devices, genotype specific therapies for patients with channelopathies, WPW, and late arrhythmic outcomes in adults with congenital heart disease. He is a former President of the Pediatric and Congenital Electrophysiology Society (PACES). Dr. Cohen continues to serve as a scientific advisor for the SADS (Sudden Arrhythmia Death Syndromes) Foundation and holds various committee positions within Heart Rhythm Society, American Heart Association, and the American College of Cardiology.
Dr Cohen has been a Visiting Professor of Pediatric Cardiology at Children’s Mercy, Duke University and Primary Children’s Hospital. Dr Cohen has been on numerous RO1 and K8 grants as well as partnered with industry for clinical research. Dr. Cohen has more than 120 published papers, authored 7 book chapters, lectured over 275 times throughout the world and has mentored numerous pediatric residents interested in cardiology. Dr Cohen is the Associate Editor for Pediatric Electrophysiology both for Cardiology in Young and World Society of Congenital Heart Surgery Journal.
Financial relationships
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Alta TherapyTopic:Sotalol Oral DrugDate added:01/11/2024Date updated:01/11/2024Relationship end date:12/31/2024